Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.290
+0.020 (1.57%)
At close: Apr 17, 2026, 4:00 PM EDT
1.300
+0.010 (0.78%)
After-hours: Apr 17, 2026, 7:33 PM EDT

Phio Pharmaceuticals Stock Forecast

PHIO's stock price has decreased by -52.22% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Phio Pharmaceuticals stock have an average target of 14, which predicts a 985.27% increase from the current stock price of 1.29.

Price Target: $14 (+985.27%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$14$14$14$14
Change+985.27%+985.27%+985.27%+985.27%
* Price targets were last updated on Feb 10, 2026.

Analyst Ratings

The average analyst rating for Phio Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy333332
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$14
Strong BuyReiterates$14+985.27%Feb 10, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$14
Strong BuyReiterates$14+985.27%Aug 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$14
Strong BuyReiterates$14+985.27%Jun 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$14
Strong BuyInitiates$14+985.27%Jun 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong BuyReiterates$4+210.08%Apr 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.97
from -1.45
EPS Next Year
-0.63
from -0.97
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-111.87-90.91-46.76-9.08-1.45-0.97-0.63
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027
High--
Avg--
Low--

EPS Forecast

EPS20262027
High-0.93-0.51
Avg-0.97-0.63
Low-0.99-0.74

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.